STCOSD
SUPN icon

Sageworth Trust Company of South Dakota’s Supernus Pharmaceuticals SUPN Stock Holding History

Sageworth Trust Company of South Dakota’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-26
Closed -$1K – 598
2022
Q2 		$1K Hold
26
– – ﹤0.01% 547
2022
Q1 		$1K Sell
26
-123
-83% -$3.77K ﹤0.01% 579
2021
Q4 		$4K Buy
+149
New +$4.52K 0.01% 568

Other funds holding SUPN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Sageworth Trust Company of South Dakota's SUPN Position: Q3 2022 in Review

Sageworth Trust Company of South Dakota sold out of Supernus Pharmaceuticals (SUPN) in Q3 2022, closing a stake of 26 shares — an estimated $1K sold.

Sageworth Trust Company of South Dakota first reported a position in SUPN in Q4 2021 and held it in 3 quarters. The position peaked at $4K in Q4 2021. 244 funds tracked by Wall St. Rank hold SUPN as of Q3 2022.

  • Sageworth Trust Company of South Dakota reported no remaining Supernus Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
  • Sageworth Trust Company of South Dakota sold 26 Supernus Pharmaceuticals shares in Q3 2022, an estimated $1K.
  • Sageworth Trust Company of South Dakota first reported a position in Supernus Pharmaceuticals in Q4 2021 and held it in 3 quarters.
  • Sageworth Trust Company of South Dakota's Supernus Pharmaceuticals position peaked at $4K in Q4 2021.
  • 244 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q3 2022.

Based on Sageworth Trust Company of South Dakota's 13F filing for Q3 2022, filed 2 Nov 2022.